CellaVision AB (publ) (CLVSF)
OTCMKTS · Delayed Price · Currency is USD
19.28
-0.63 (-3.16%)
At close: Jan 23, 2025
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of $478.52 million as of October 24, 2025. Its market cap has decreased by -26.74% in one year.
Market Cap
478.52M
Enterprise Value
465.20M
Revenue
79.02M
Ranking
n/a
PE Ratio
30.10
Stock Price
$19.28
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 54.35M to 478.52M, an increase of 780.43%. That is a compound annual growth rate of 12.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 478.52M | 1.88% |
| Dec 30, 2024 | 469.69M | -6.32% |
| Dec 29, 2023 | 501.37M | -4.32% |
| Dec 30, 2022 | 523.98M | -38.89% |
| Dec 30, 2021 | 857.50M | -4.04% |
| Dec 30, 2020 | 893.58M | 9.30% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 649.45M |
| Glass House Brands | 618.32M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| Northwest Biotherapeutics | 305.00M |
| American Oncology Network | 297.14M |